Science Translational Medicine

Article	Citations
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment	480
Stronger regulation of AI in biomedicine	365
A tale of two cells: Regulatory T cell–microglia cross-talk in the ischemic brain	305
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans	272
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome	256
Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics	249
Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice	230
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection	224
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms	224
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England	217
Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans	213
Evolution of inflammation and immunity in a dengue virus 1 human infection model	210
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine	205
Engineering CAR-T therapies for autoimmune disease and beyond	205
In vivo gene immunotherapy for cancer	196
Point-of-care diagnostic tests for tuberculosis disease	185
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting	179
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant	174
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies	172
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care	162
AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer	160
Increased brain microvascular hemoglobin concentrations in children with cerebral malaria	160
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer	160
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer	159
TrkA-mediated sensory innervation of injured mouse tendon supports tendon sheath progenitor cell expansion and tendon repair	154

SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery	153
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens	150
Advancing beyond the twists and turns of T cell exhaustion in cancer	141
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 + T cells	141
Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging	137
Antigenic distance between primary and secondary dengue infections correlates with disease risk	137
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment	134
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes	133
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors	131
Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation	128
Erratum for the Research Article: “The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis” by S. S. Pullamsetti, R. Savai, R. Dumitrascu, B. K. Dahal, J. Wilhelm, M. Koni	126
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis	123
Generating functionally stable and antigen-specific T reg cells from effector T cells for cell therapy of inflammatory diseases	123
Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons	122
Development and preclinical validation of 2-deoxy 2-[ 18 F]fluorocellobiose as an Aspergillus -specific PET tracer	121
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models	120
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease	119
Nociceptor-to-macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth in mice	117
NAD + precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunction	117
Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation	117
FcγR-targeted tuftsin clusters rejuvenate macrophages in preclinical sepsis–associated secondary infection	116
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa	114
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease	114
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis	114
Sexually dimorphic differences in angiogenesis markers are associated with brain aging trajectories in humans	114
The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC–derived sensory neurons	111
Disrupting mechanotransduction decreases fibrosis and contracture in split-thickness skin grafting	110
Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation	110
Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection	110
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe	109
Molecular hallmarks of hydrocephalus	107
Next-generation CAR T cell therapies for glioblastoma	107
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas	106
Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager	106
BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease	106
Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models	105
TREM1 activation of myeloid cells promotes antitumor immunity	105
Integrating the gut microbiome and pharmacology	105
Translating insights into therapies for Long Covid	104
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer	102
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia	101
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron	101
PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistry	100
The pancreatic clock is a key determinant of pancreatic fibrosis progression and exocrine dysfunction	100
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy	100
Improved control of a prosthetic limb by surgically creating electro-neuromuscular constructs with implanted electrodes	99
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)	99
Anakinra restores immunological misfiring that drives influenza-associated pulmonary aspergillosis	98
A nose for tau	98
Short-course combination treatment for experimental chronic Chagas disease	97

Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice	97
Postoperative adhesions are abrogated by a sustained-release anti-JUN therapeutic in preclinical models	96
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis	96
The m 6 A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus	95
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses	93
Innate PD-L1 limits T cell–mediated adipose tissue inflammation and ameliorates diet-induced obesity	93
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort	92
Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model	92
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment	92
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants	91
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease	91
CD23 + IgG1 + memory B cells are poised to switch to pathogenic IgE production in food allergy	91
T cell receptor precision editing of regulatory T cells for celiac disease	90
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial	89
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria	88
Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders	88
Obesity and lifespan, a complex tango	86
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria	86
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer	85
Adaptive cognitive control circuit changes associated with problem-solving ability and depression symptom outcomes over 24 months	84
Cationic nanogel–based nasal therapeutic HPV vaccine prevents the development of cervical cancer	84
Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors	83
Diet shapes the metabolite profile in the intact human ileum, which affects PYY release	83
Wastewater surveillance facilitates climate change–resilient pathogen monitoring	83
Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosis	83
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration	83
Harnessing regulatory T cells to establish immune tolerance	82
Assessment of cholesterol homeostasis in the living human brain	82
Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice	80
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes	79
Myeloid MAS–driven macrophage efferocytosis promotes resolution in ischemia-stressed mouse and human livers	79
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis	79
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis	79
Erratum for the Research Article “A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer” by A. M. Miller et al<	78
Metabolic surgery reduces CRC disease progression through circulating bile acid diversion	78
IgE in allergy: It takes two	78
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis	78
Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy	78
Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention	77
Inhibiting SLC38A2 lowers blood pressure in rodent models of hypertension	76
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection	76
A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins	76
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19	74
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor	74
A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice	74
Green light analgesia in mice is mediated by visual activation of enkephalinergic neurons in the ventrolateral geniculate nucleus	74
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans	73
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria	73
Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection	73
Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice	73
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia	73
Sex, lean body mass, and cardiac performance	72
NFIA regulates articular chondrocyte fatty acid metabolism and joint homeostasis	72
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice	72
Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice	72
Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice	71
Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice	71
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis	71
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis	71
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation	71
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing	70
Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair	70
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice	70
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases	69
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis	69
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer	69
Tissue-resident CD8 + T cells drive compartmentalized and chronic autoimmune damage against CNS neurons	69
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models	68
Targeting cytokines in inflammatory bowel disease	68
Synthetic biology–driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer	68
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection	67
Erratum for the Research Article “Platelet-derived growth factor C signaling is a potential therapeutic target for radiation proctopathy” by W. Lu et al .	66
Comment on “A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk”	65
Erratum for the Research Article “Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4” by Y. Ren et al .	64
Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models	64
Dietary saturated fatty acids promote lung myeloid cell inflammasome activation and IL-1β–mediated inflammation in mice and humans	64
Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer’s disease	64
Genetic and structural aspects of amyloid diseases	64
A replicating RNA vaccine protects cynomolgus macaques against lethal clade 2.3.4.4b influenza A H5N1 virus challenge	63
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma	63

Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration	63
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity	63
Allergy: Mechanistic insights into new methods of prevention and therapy	62
Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device	62
Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants	62
NF-κB perturbation reveals unique immunomodulatory functions in Prx1 + fibroblasts that promote development of atopic dermatitis	62
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer	61
Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets	61
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos	61
Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging	61
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers	61
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice	61
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease	60
Spatial genomics: Mapping the landscape of fibrosis	60
Delivery of therapeutic carbon monoxide by gas-entrapping materials	60
Resident microbes shape the vaginal epithelial glycan landscape	60
Seeking satiety: From signals to solutions	60
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis	59
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection	59
Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology	58
Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases	58
New government drug repurposing programs: Opportunities and uncertainties	58
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer	58
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6	58
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease	58
Neuroinflammation: An astrocyte perspective	57
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease	57
Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models	57
Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit	57
Interleukin-2–based therapies in cancer	57
Where do the pathogens that cause surgical site infections come from?	56
Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models	56
Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease	55
Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression	55
Targeting SIRT2 induces MLH1 deficiency and boosts antitumor immunity in preclinical colorectal cancer models	55
Donor-derived regulatory dendritic cell infusion modulates effector CD8+T cell and NK cell responses after liver transplantation	54
Predicting the next round of drugs for Medicare price negotiation	53
Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase	53
Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling	53
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques	53
A mouse model of chronic primary pain that integrates clinically relevant genetic vulnerability, stress, and minor injury	53
Erratum for the Research Article “Boosting systemic absorption of peptides with a bioinspired buccal-stretching patch,” by Z. Luo et al .	53
Provocateurs of autoimmunity within the gut microbiota	53
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques	53
Neuronal population activity in the olivocerebellum encodes the frequency of essential tremor in mice and patients	52
Response to Comment on “Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases”	52
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human	52
Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy	52
Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy	51
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease	51
GABABreceptor modulation of visual sensory processing in adults with and without autism spectrum disorder	51
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem–specific human B cells	51
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma	51
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model	50
Chemogenetics identifies separate area 25 brain circuits involved in anhedonia and anxiety in marmosets	50
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19	50
Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid	49
An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus	49
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses	48
Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis	48
A prM mutation that attenuates dengue virus replication in human cells enhances midgut infection in mosquitoes	48
Learning CNS immunopathology from therapeutic interventions	48
Targeting brain hubs of ictal fast ripple activity to reduce seizures in patients with drug-resistant epilepsy	48
Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy	47
The protein kinase C modulator bryostatin-1 therapeutically targets microglia to attenuate neuroinflammation and promote remyelination	47
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer	47
Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”	47
Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis	47
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo	47
Pathophysiology of Dyt1- Tor1a dystonia in mice is mediated by spinal neural circuit dysfunction	47
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity	47
A bioinspired mineralized collagen scaffold promotes enthesis healing and activates Gli1 expression in preclinical models	46
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML	46
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity	46
A new chapter in lipid signaling and kidney fibrosis	45
Keratinocytes: From passive targets to active mediators of systemic autoimmunity	45
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19	45
An identity crisis for lung cancer cells	45
DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosis	45
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency	45
Bruton’s tyrosine kinase inhibitors rescue neuronal impairment caused by B cell–mediated lymphotoxin-α release	45
Erratum for the Research Article “Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia” by R. Sartori et al .	45
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcers	45
Human inner ear fluid imbalance detected by optical coherence tomography correlates with hearing loss	44
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections	44
TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure	44
Eliminating interactions with the viral Fc receptor improves antibody-mediated protection against neonatal HSV infection in mice	44
Guanosine diphosphate–mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer	44
Hemodynamic evaluation of biomaterial-based surgery for Tetralogy of Fallot using a biorobotic heart, in silico, and ovine models	44
Visualization of exhaled breath metabolites reveals distinct diagnostic signatures for acute cardiorespiratory breathlessness	44
Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis	44
Increased β 2 -adrenergic signaling promotes fracture healing through callus neovascularization in mice	44
Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease	44
Targeting the PDE3B-cAMP-autophagy axis prevents liver injury in long-term supercooling liver preservation	44
Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence	43